About Diligent Pharma
Diligent is a Quality and Risk Management organization with a central platform for driving speed, efficiency, and high compliance in clinical trial vendor qualification.
We are the clinical trial industry’s leading vendor qualification ecosystem, connecting pharma and biotech sponsors to a global network of Diligent Qualified GCP and GCLP vendors.
Our Mission
To streamline Sponsor-Vendor engagements while ensuring global compliance, maintaining data integrity, and ultimately accelerating treatment delivery to patients.
Diligent is accelerating clinical trial execution by helping Sponsors onboard clinical Vendors faster and by helping Vendors get to contract with Sponsors more quickly.
We achieve this by eliminating the need for each Sponsor to conduct identical and repetitive qualifications of the same Vendor.
Who we are
When you join our platform, you gain more than technology. You tap into our extensive experience across diverse clinical and quality applications for a holistic understanding of research intricacies and global standards, along with the unique, pioneering perspective needed to stay ahead of clinical trial innovation and audit modernization.
![Patty-Leuchten Patty Leuchten](https://www.diligentpharma.com/wp-content/uploads/2023/04/Patty-Leuchten.jpg)
Patricia Leuchten
CEO and Founder
A pharma industry leader and entrepreneur with a focus on driving improvements in clinical trial execution, at scale, through innovative solutions. In 1999, she founded The Avoca Group, whose Avoca Quality Consortium paved the way for Diligent Pharma and the Diligent Qualification Platform.
![Jennifer-Sessions Chris Otto Interview](https://www.diligentpharma.com/wp-content/uploads/2023/04/Jennifer-Sessions-1.jpg)
Jennifer Sessions, MS, LLS Certified
Vice President, Client Services
25+ years in research and development experience in industry including Eli Lilly & Co, academia, and biotechnology sectors in Clinical Development, Clinical Operations, Clinical Trial Management, Lean Six Sigma, Pharmaceutical Project Management, Vendor Relationship Management and Process Optimization and Improvement
![Chris-Casazza Patty Leuchten](https://www.diligentpharma.com/wp-content/uploads/2023/04/Chris-Casazza.jpg)
Chris Casazza
Chief Commercial Officer
23+ years of Commercialization and R&D commercial team leadership on the service side of the Pharma/BioPharma industry. Chris has held senior leadership positions at Kantar Health leading the US Client Consulting Services sales team, as well as Chief Commercial Officer of YourEncore with a transition to a leader of the Consulting organization at Advarra when acquired.
![Chris Sallemi Chris Sallemi](https://www.diligentpharma.com/wp-content/uploads/2024/07/Bio-pic-650x650-2.png)
Christopher Sallemi
Chief Technology Officer & Head of the Diligent Innovation Lab
20+ years of technology leadership experience in the defense, financial services, and pharma industries. Chris has a proven track record in delivering modern cloud-based, secure, beautifully crafted, and responsive software products. Prior to Diligent Pharma, Chris was the CTO at STP Investments Services for over 13 years and previously a Senior Software Engineer at Lockheed Martin.
![Anthea Dransfield The Diligent provider qualification model](https://www.diligentpharma.com/wp-content/uploads/2024/05/Anthea-Dransfield.png)
Anthea Dransfield
Head of Quality
With over 30 years in the pharmaceutical industry, Anthea has held various operational and quality leadership roles, covering cGMP, clinical site operations, technical validation, and GxP quality oversight. Anthea advocates for risk-based, compliance-focused approaches and leverages technology to enhance quality processes.
Currently, Anthea leads Diligent’s quality and risk frameworks, ensuring effective business practices and high-quality work products.
![Greg-Bell Chris Otto Interview](https://www.diligentpharma.com/wp-content/uploads/2023/04/Greg-Bell.jpg)
Greg Bell, CPA
Head of Finance and Administration
30+ years as a Senior Financial Executive for healthcare, technology and financial services companies, including 15+ years in leadership roles for SaaS-based software companies. Most recently, he served as Chief Operating Officer at EREflow.
![Dan Lynn headshot Chris Otto Interview](https://www.diligentpharma.com/wp-content/uploads/2024/06/Bio-pic-650x650-1.png)
Dan Lynn, MBA
Head of Product Strategy
30+ years of experience in strategy, product management, sales, marketing, technology development, and finance. Dan founded and led DigitalGrit and RelevantNoise, and held senior roles at ADP, Inc. and AT&T, including at Bell Laboratories. He also advised Avoca on product, marketing, and sales strategies.
At Diligent, Dan advises on strategic projects and cross-functional initiatives. He holds an MBA from Rutgers University.
![Syed Mujtaba Syed Mujtaba](https://www.diligentpharma.com/wp-content/uploads/2023/11/Bio-pic-650x650-1.png)
Syed Mujtaba
Director of Product Development
Syed is an experienced senior leader in technology and software development, with two decades of expertise in overseeing technical operations, driving product innovation, and shaping software architecture.
Work with us
Join the Diligent team and become a catalyst for positive change in clinical research. Embark on a rewarding journey as we navigate through exciting early growth. We’re looking for individuals with enthusiasm and passion. If you want an employer that values entrepreneurship, creativity, diversity, and a healthy work-life balance, then Diligent might be the place for you.
Questions? Let’s chat.
Schedule a one-on-one with our team to learn more about how Diligent can support your unique qualification and risk management needs.